Integral Investment Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$251K Buy
10,438
+725
+7% +$19K 0.06% 159
2026
Q1
$273K Sell
9,713
-505
-5% -$13.4K 0.07% 148
2025
Q4
$254K Sell
10,218
-1,340
-12% -$33.8K 0.06% 153
2025
Q3
$294K Sell
11,558
-6,709
-37% -$166K 0.08% 132
2025
Q2
$443K Sell
18,267
-11,220
-38% -$262K 0.13% 106
2025
Q1
$747K Sell
29,487
-26,038
-47% -$681K 0.24% 77
2024
Q4
$1.47M Buy
55,525
+2,385
+4% +$64.7K 0.48% 40
2024
Q3
$1.54M Sell
53,140
-102
-0.2% -$2.98K 0.52% 39
2024
Q2
$1.48M Buy
53,242
+13,992
+36% +$385K 0.55% 38
2024
Q1
$1.09M Buy
39,250
+19,737
+101% +$548K 0.45% 37
2023
Q4
$562K Buy
19,513
+2,649
+16% +$80.1K 0.36% 51
2023
Q3
$559K Sell
16,864
-750
-4% -$26.5K 0.39% 48
2023
Q2
$646K Buy
17,614
+96
+0.5% +$3.74K 0.43% 44
2023
Q1
$715K Buy
17,518
+169
+1% +$7.3K 0.51% 36
2022
Q4
$889K Buy
17,349
+173
+1% +$8.29K 0.69% 22
2022
Q3
$752K Sell
17,176
-1,232
-7% -$59.9K 0.61% 31
2022
Q2
$965K Sell
18,408
-1,403
-7% -$71.5K 0.82% 23
2022
Q1
$1.03M Buy
19,811
+1,860
+10% +$96.5K 0.64% 36
2021
Q4
$1.06M Buy
+17,951
New +$889K 0.76% 28

Other funds holding PFE

Integral Investment Advisors's PFE Position: Q2 2026 in Review

Integral Investment Advisors increased its Pfizer (PFE) stake by 7.5% in Q2 2026, buying an estimated $19K and bringing the position to 10,438 shares worth $251K. The position accounts for 0.06% of the portfolio, ranked #159.

Integral Investment Advisors first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.54M in Q3 2024. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Integral Investment Advisors held 10,438 shares of Pfizer worth $251K as of Q2 2026.
  • Integral Investment Advisors bought 725 Pfizer shares in Q2 2026, an estimated $19K.
  • Pfizer made up 0.06% of Integral Investment Advisors's portfolio in Q2 2026, its #159 holding.
  • Integral Investment Advisors first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
  • Integral Investment Advisors's Pfizer position peaked at $1.54M in Q3 2024.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Integral Investment Advisors's 13F filing for Q2 2026, filed 7 Jul 2026.